Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 of  45,237 نتائج ل ""Local""

فلترة النتائج

Subject : antineoplastic combined chemotherapy protocols Subject : medicine.disease فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China.

  • Authors : Han X; Department of Hematology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Jiang X

Subjects: Thalidomide*/Thalidomide*/Thalidomide*/*analogs & derivatives; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/mortality

  • Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (9), pp. e7232.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Neoadjuvant Chemotherapy in Patients with HER2-Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran.

  • Authors : Roudini K; Department of Hematology and Medical Oncology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.; Mirzania M

Subjects: Neoadjuvant Therapy* ; Receptor, ErbB-2*/Receptor, ErbB-2*/Receptor, ErbB-2*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

  • Source: Archives of Iranian medicine [Arch Iran Med] 2024 Apr 01; Vol. 27 (4), pp. 206-215. Date of Electronic Publication: 2024 Apr 01.Publisher: Academy of Medical Sciences of I.R. Iran Country of Publication: Iran NLM ID: 100889644 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/drug therapy ; Lymphoma*/Lymphoma*/Lymphoma*/drug therapy

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3063-3071. Date of Electronic Publication: 2022 Aug 17.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.

  • Authors : Al-Ezzi EM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.; Zahralliyali A

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Neoplasms, Germ Cell and Embryonal*/Neoplasms, Germ Cell and Embryonal*/Neoplasms, Germ Cell and Embryonal*/drug therapy; Male Testicular Germ Cell Tumor

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Jun 27; Vol. 30 (7), pp. 6166-6176. Date of Electronic Publication: 2023 Jun 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease.

  • Authors : Byun JM; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.; Min CK

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Neoplasm Recurrence, Local*/Neoplasm Recurrence, Local*/Neoplasm Recurrence, Local*/drug therapy

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2022 Oct 23; Vol. 15 (1), pp. 150. Date of Electronic Publication: 2022 Oct 23.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma.

  • Authors : Zhang Q; Department of Internal Medicine-Oncology, Cancer Hospital of Harbin Medical University, Harbin, China.; Tao R

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Lymphoma, B-Cell*/Lymphoma, B-Cell*/Lymphoma, B-Cell*/drug therapy ; Lymphoma, B-Cell*/Lymphoma, B-Cell*/Lymphoma, B-Cell*/pathology

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2022 Oct; Vol. 63 (10), pp. 2503-2506. Date of Electronic Publication: 2022 Jul 19.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort study.

  • Authors : Muhammadzai J; College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.; Haider K

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Chemotherapy, Adjuvant/Chemotherapy, Adjuvant/Chemotherapy, Adjuvant/*mortality ; Neoplasm Recurrence, Local/Neoplasm Recurrence, Local/Neoplasm Recurrence, Local/*mortality

  • Source: PloS one [PLoS One] 2022 Feb 02; Vol. 17 (2), pp. e0263250. Date of Electronic Publication: 2022 Feb 02 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.

  • Authors : Pan D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Kaufman JL

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Bortezomib/Bortezomib/Bortezomib/*administration & dosage ; Dexamethasone/Dexamethasone/Dexamethasone/*administration & dosage

  • Source: Cancer medicine [Cancer Med] 2022 Jan; Vol. 11 (2), pp. 358-370. Date of Electronic Publication: 2021 Dec 17.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression.

  • Authors : Hindi N; Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), 28040 Madrid, Spain.; Medical Oncology Department, University Hospital General de Villalba, 28400 Madrid, Spain.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; HMGB1 Protein*/HMGB1 Protein*/HMGB1 Protein*/metabolism ; Rhabdomyosarcoma, Embryonal*/Rhabdomyosarcoma, Embryonal*/Rhabdomyosarcoma, Embryonal*/drug therapy BOMP protocol; ICE protocol 1

  • Source: International journal of molecular sciences [Int J Mol Sci] 2023 Jan 03; Vol. 24 (1). Date of Electronic Publication: 2023 Jan 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case series.

  • Authors : Djebbari F; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Poynton M

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Dexamethasone/Dexamethasone/Dexamethasone/*therapeutic use

  • Source: Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 204-207.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 of  45,237 نتائج ل ""Local""